TW200514559A - Novel use of cannabinoid receptor agonist - Google Patents
Novel use of cannabinoid receptor agonistInfo
- Publication number
- TW200514559A TW200514559A TW093124603A TW93124603A TW200514559A TW 200514559 A TW200514559 A TW 200514559A TW 093124603 A TW093124603 A TW 093124603A TW 93124603 A TW93124603 A TW 93124603A TW 200514559 A TW200514559 A TW 200514559A
- Authority
- TW
- Taiwan
- Prior art keywords
- optionally substituted
- group
- alkyl group
- substituted alkyl
- optionally
- Prior art date
Links
- 229940121376 cannabinoid receptor agonist Drugs 0.000 title 1
- 239000003537 cannabinoid receptor agonist Substances 0.000 title 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 239000003112 inhibitor Substances 0.000 abstract 3
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 241001601725 Sthenias Species 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 125000005156 substituted alkylene group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003294114 | 2003-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200514559A true TW200514559A (en) | 2005-05-01 |
Family
ID=34191020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093124603A TW200514559A (en) | 2003-08-18 | 2004-08-17 | Novel use of cannabinoid receptor agonist |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070027144A1 (zh) |
| EP (1) | EP1661572A1 (zh) |
| JP (1) | JPWO2005016351A1 (zh) |
| CN (1) | CN1867339A (zh) |
| TW (1) | TW200514559A (zh) |
| WO (1) | WO2005016351A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2006080287A1 (ja) * | 2005-01-25 | 2008-06-19 | 塩野義製薬株式会社 | ２−アゾリルイミノ−１，３−チアジン誘導体 |
| US8354435B2 (en) | 2008-09-08 | 2013-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| CN102202669A (zh) | 2008-10-28 | 2011-09-28 | 利兰·斯坦福青年大学托管委员会 | 醛脱氢酶调节剂及其使用方法 |
| US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| WO2014160185A2 (en) | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532237A (en) * | 1995-02-15 | 1996-07-02 | Merck Frosst Canada, Inc. | Indole derivatives with affinity for the cannabinoid receptor |
| JP2000256323A (ja) * | 1999-01-08 | 2000-09-19 | Japan Tobacco Inc | ２−オキソキノリン化合物及びその医薬用途 |
| CN1247553C (zh) * | 1999-09-14 | 2006-03-29 | 盐野义制药株式会社 | 2－亚氨基－1,3－噻嗪衍生物 |
| CZ2003284A3 (cs) * | 2000-08-01 | 2003-09-17 | Ono Pharmaceutical Co., Ltd. | 3,4-Dihydroisochinolinový derivát a farmaceutické činidlo obsahující tento derivát jako účinnou složku |
| KR100828982B1 (ko) * | 2000-12-28 | 2008-05-14 | 시오노기세이야쿠가부시키가이샤 | 칸나비노이드 2형 수용체 친화 작용을 갖는 피리돈 유도체 |
| EP1375489B1 (en) * | 2001-03-08 | 2008-08-20 | Shionogi & Co., Ltd. | Medicinal composition containing 1,3-thiazine derivative |
| WO2003061699A1 (en) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedies for allergic diseases |
| DE60319714T2 (de) * | 2002-06-19 | 2009-04-02 | Schering Corp. | Agonisten des cannabinoidrezeptors |
-
2004
- 2004-08-16 EP EP04771706A patent/EP1661572A1/en not_active Withdrawn
- 2004-08-16 US US10/567,754 patent/US20070027144A1/en not_active Abandoned
- 2004-08-16 WO PCT/JP2004/011745 patent/WO2005016351A1/ja not_active Ceased
- 2004-08-16 JP JP2005513191A patent/JPWO2005016351A1/ja not_active Withdrawn
- 2004-08-16 CN CNA2004800304162A patent/CN1867339A/zh active Pending
- 2004-08-17 TW TW093124603A patent/TW200514559A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2005016351A1 (ja) | 2006-10-12 |
| EP1661572A1 (en) | 2006-05-31 |
| US20070027144A1 (en) | 2007-02-01 |
| CN1867339A (zh) | 2006-11-22 |
| WO2005016351A1 (ja) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
| TW200503724A (en) | Novel pharmaceuticals | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| DE60204674D1 (de) | Retinoid x rezeptormodulatoren | |
| DE60130771D1 (de) | Substituierte heterocyclische amide | |
| GB0127903D0 (en) | Improvements relating to organic compounds | |
| SE0100903D0 (sv) | Compounds | |
| ATE417841T1 (de) | Furanderivate als ep4-rezeptorantagonisten | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| ATE505462T1 (de) | Neue biologischaktive molekü le | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| TW200514559A (en) | Novel use of cannabinoid receptor agonist | |
| PL1692098T3 (pl) | Pochodna alfa-ketomidu oraz sposób jej wytwarzania i zastosowanie | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| NO20080839L (no) | Isotopsubstituerte protonpumpeinhibitorer | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| ZA200500436B (en) | 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
| GB0215392D0 (en) | Chemical compounds | |
| HRP20020440B1 (en) | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof | |
| HRP20110780T1 (hr) | Aminoarilsulfonamidni spojevi i njihova upotreba kao ligandi 5-ht6 | |
| CY1107481T1 (el) | Εναντιοεκλεκτικη αλκυλιωση τρικυκλικων ενωσεων | |
| DE602004031878D1 (de) | Immunhemmende pyrazolon-verbindungen | |
| MXPA05012004A (es) | Nuevos bioisosteros de actinonina. | |
| IL182575A0 (en) | On-resin peptide cyclization |